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ENDOTHELIN-1 FOCALLY 
CONSTRICTS PULMONARY 
VEINS IN RATS 
Serum endothelin levels increase during sepsis, ischemia, reperfusion, pulmo- 
nary operations, and systemic hypertension after surgery. Despite extensive 
study, the site and extent of action of endothelin on the pulmonary microcir- 
culation are not well established. To assess the e~ect of endothelin on the 
pulmonary vasculature, specially the veins, the circulation of the lung was cast 
with methyl methacrylate 10 minutes after endothelin-1 was given intrave- 
nously to rats. Endothelin-1, at concentrations of 0.1, 1.0, and 10.0/xg/kg of 
body weight, increased the mean systemic arterial blood pressure 8%, 7%, and 
17% (p < 0.01) and mean pulmonary arterial blood pressure 15%, 28%, and 
53%, respectively (p < 0.01). The proportional increases in the pulmonary 
pressures were greater than those of the systemic pressures (p < 0.01). 
Scanning electron microscopy of cast blood vessels howed more contraction of 
the veins than the arteries. For doses of 0, 0.1, 1.0, and 10.0 /xg/kg, the 
respective focal contraction of small veins was 6.7% (-+4.4), 15.4% (_9.1), 
23.3% (-10.1), and 14.4% (---9.0) of the vessel diameter (p < 0.01). In addition, 
the diameters of capillaries increased (p < 0.01) and the capillary interspaces 
decreased (p < 0.01) after endothelin administration, but not in a linear 
dose-dependent manner. The dose of endothelin correlated with the change in 
the mean systemic (r = 0.82,p < 0.01) and the mean pulmonary (r = 0.80,p < 
0.01) blood pressures. The mean pulmonary pressure change correlated with 
the focal venous contraction on the casts (r = 0.35, p < 0.01), capillary 
diameter (r = 0.64,p < 0.01), and capillary interspace distance (r = -0.34,p < 
0.01). The venous contraction was related to the capillary diameter (r = 0.26, 
p < 0.01). The most notable elect of endothelin-1 in rat pulmonary microcir- 
culation is focal constriction of small veins. Because this e~ect may lead to 
pulmonary edema, endothelin antagonists may be of benefit in a variety of 
clinical situations. (J TrIORAC CARDIOVASC SURG 1995;110:148-56) 
S. Aharinejad, MD, PhD,* D. E. Schraufnagel, MD,** A. Miksovsky, MD,*** 
E. K. Larson, MS,**** and S. C. Marks, Jr., DDS, PhD,**** Worcester, Mass. 
[~ndothel in-1, a 21-residue peptide first isolated 
1 I . . f rom endothelial cell cultures, has important 
effects on vascular smooth muscle. 2Endothel in con- 
trois regional perfusion of  the lung 3 and its serum 
level increases during sepsis, 4 ischemia, 5 reperfu- 
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sion, 6 and pulmonary operations. 7 Endothel in plays 
a role in vascular restenosis in patients undergoing 
angioplasty s and contracts bronchi in experimental 
lung transplantation i dogs. 9 It has been associated 
with systemic hypertension after liver transplanta- 
tion. 1~ Although its effects are largely vasoconstric- 
tive, 11 an initial vasodilatory effect of endothelin-1 
occurs in certain young animal species) 2' 13 Endo- 
thelin-1 causes a biphasic response in the systemic 
vasculature and increases myocardial contractility in 
adult rabbits, although the reason for the initial 
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dilation remains uncertain. 14 There is disagreement 
about the location of  action and its magnitude in 
response to specific doses. 15 Fortes, de Nucci, and 
Garcia-Leme 16 found it constricts both peripheral 
arteries and veins, but Brain 17 found that endothel in 
did not affect peripheral veins. Synthesized by the 
pulmonary vasculature, TM endothelin increases pul- 
monary vascular resistance, a9-22 Endothel in is in- 
creased in the alveoli of animals that have been 
experimentally injured z3 and in the serum of pa- 
tients who have pulmonary hypertension 24-27 and 
those who undergo heart transplantation. 28 
Most studies of the effect of endothelin on the 
pulmonary vasculature have used physiologic mea- 
surements, such as the pressure generated by the 
shortening of smooth muscle or the resistance to 
pulmonary blood flow. Although these studies give 
important functional information they do not show 
the site of  action, especially on the small pulmonary 
blood vessels. We were interested in the effect of  
endothelin-1 on the pulmonary vascular bed espe- 
cially as concerns the veins, which we have studied 
earlier.29, 30 We used vascular casts examined with 
scanning electron microscopy, which show changes 
in three dimensions in disease 3~ and after the appli- 
cation of  vasoactive drugs. 32 Understanding these 
effects contributes to our understanding of  pulmo- 
nary vascular eactions in patients undergoing sur- 
gery. 
Methods 
This experiment was approved by the Animal Care 
Committee at the University of Massachusetts Medical 
Center at Worcester. The animals were handled humanely 
according to the Public Health Service guidelines. 
Blood pressure measurements. We divided 24 male 
Wistar Kyoto rats (Charles River, Boston, Mass.) weigh- 
ing 160 to 320 gm into four groups and anesthetized them 
with diethyl ether (Metofane; Fisher Chemicals, Chicago, 
Ill.). We opened the abdomen, cannulated the aorta, and 
connected the cannula to a transducer that recorded 
blood pressure on a Grass polygraph (Grass, Quincy, 
Mass.). We connected a 24-gange Teflon catheter with an 
outer diameter of 0.99 mm, an inner diameter of 0.66 mm, 
and a tip shaped into an "R crook" to a transducer and 
placed it into a metal cannula. 33 The cannula was inserted 
into the right jugular vein and advanced into the right 
ventricle until the typical right ventricular pressure wave- 
33 form was obtained. After recording the pressure, we 
plied the catheter into the pulmonary artery and recorded 
the pressure again. Then, the caudal vena cava was 
cannulated at the level of the renal arteries with a 
20-gauge catheter. The rats were given 0, 0.1, 1.0, or 10/xg 
of endotheliml per kilogram of body weight through the 
caudal vena cava and both systemic and pulmonary arte- 
rial pressures were again recorded. The different doses of 
endothelin-1 were selected on the basis of previous re- 
ports2O, 22, 34 and correlated with pharmacologic dosesY 
In pilot studies in a group of animals - in which the lungs 
were not cast, the vasoconstrictor effect of endothelin-1 
lasted 35 (---7) minutes before the blood pressure gradu- 
ally decreased to the baseline level. The body temperature 
was maintained with use of a heat lamp. Animals recov- 
ered from the surgical procedure for 30 minutes before 
baseline blood pressures were recorded and any drug 
administered. 
Cast preparation. Ten minutes after the endothelin 
injection, the catheter in the jugular vein was clamped. 
The vasculature was flushed with 20% dextran 40 in 0.9% 
saline (Macrodex; Pharmacia, Piscataway, N.J.) with 5000 
IU/L of heparin at 42~ through the caudal vena cava 
until the aortic etflux cleared. This required about 60 ml of 
solution. 3~ Then, 20 ml of methyl methacrylate (Mercox; 
Ladd Industries, Burlington, Vt.), mixed with 2 gm of 
catalyst, was injected over about 1 minute through the 
vena cava to cast the lungs. 36 After hardening at room 
temperature for 2 hours, the lungs were dissected out and 
transferred to a 60 ~ C water bath overnight. The tissue was 
macerated in a 5% potassium hydroxide solution at 40 ~ C 
for 6 days. 3~ The specimens were rinsed with tap water for 
30 minutes, with 5% formic acid for 10 minutes, and then 
with three rinses in distilled water for 2 minutes each. 31 
The casts were frozen in distilled water, freeze-dried, cut 
with scissors into 1 to 2 mm thick slices, and mounted onto 
studs with silver paste and conductive bridges. 37 The casts 
were sputter coated with palladium-gold for 3 minutes and 
examined with a JEOL JSM-35C scanning electron micro- 
scope (JEOL, Tokyo, Japan) at an accelerating voltage of 
10 kV. 
Specimens were coded so that the microscopist was 
unaware of the group to which they belonged. From each 
lung we mounted four slices on aluminum studs. On each 
stud we studied four arteries, four veins, and four alveolar 
fields. The fields containing the arteries and veins were 
selected randomly at 200-fold magnification. Those con- 
taining alveoli were also selected randomly at 1000-fold 
magnification. We looked for changes in the surface and 
caliber of the arteries and veins. 31' 38 Casts of arteries are 
distinguishable from those of veins because the nuclei of 
arterial endothelial cells imprint oval impressions that run 
with the long axis of the vessel. The nuclei of venous 
endothelial cells imprint round impressions that have no 
direction. 39 Arteries track with the airways; veins lie apart. 
Veins have regular ring-shaped indentations; arteries do 
not. The depths of the contractions in the veins were 
measured by the method of Schraufnagel and Thakkar. 32 
Briefly, the casts were fractured at the constricted sites of 
the blood vessels. The constricted sites were rotated 
perpendicular to the viewing plane of the scanning elec- 
tron microscope. The constricted diameter and outer 
vessel diameter were measured at the same site. One 
minus the inner constricted segment divided by the outer 
diameter of the cast was the percentage of contraction. 
Cast alveolar capillaries cover most of the alveolus but 
leave a small opening between spokes in their hub-and- 
spoke configuration. In each alveolar capillary basket, the 
horizontal distances of 10 capillary interspaces ( canning 
from top to bottom) were measured. ~ In separate areas, we 
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Fig. 1. A, Stippled columns represent mean systemic ar- 
terial blood pressures before injection of endothelinJ Solid 
columns represent mean systemic blood .pressure after 
endotheli n injection. B, Stippled columns represent mean 
pulmonary arterial blood pressures before injection of 
endothelin. Solid columns represent mean pulmonary 
blood pressures after endothelin injection. Endothelin-1 
increases blood pressure in both circulations. 
measured the diameters of the capillaries. A transparent 
plastic overlay with a test pattern 4~ was put onthe cathode 
ray tube of the scanning electron microscope, Capillaries 
beneath the marked points were measured: 10 capillaries 
per field and 4 fields per stud at 1000-fold magnification. 
Data analysis. The variables analyzed were the ani- 
mal's body weight and age; pulmonary and systemic 
arterial systolic, diastolic, and mean pressures; diameters 
of the veins; depths of venous contraction i  percentage; 
diameters of the capillaries; and widths of the interspaces 
between alveolar capillary casts. The pressures were com- 
pared before and after endothelin administration (one 
dose for each animal) by paired t tests. We compared 
these factors with the dose of endothelin as the indepen- 
dent variable and with the focal venous contraction as the 
dependent variable by an analysis of variance and multi- 
variate regression. We used the Student-Newman-Keuls 
multiple range procedure to show where the differences 
were. The dose of endothelin was evaluated both as a 
continuous and categoric variable, We concluded that 
differences were significant if the p value was <0.01. 
Because correlations included many comparisons, the p 
value was divided by the number of tests performed 
(Bonferronip). 41The standard eviation isdisplayed after 
the plus or minus sign. Statistics were done on a Dell 310 
microcomputer (Dell Computer Corp., Austin, Tex.) run- 
ning SAS statistical software for DOS, release 6.03. 42 
Results 
Endothelin-1, at concentrations of 0.1, 1.0, and 
10.0/xg/kg body weight, increased the mean systemic 
blood pressure 10, 7, and 17 mm Hg and the mean 
pulmonary artery blood pressure 2, 4, and 7 mm Hg, 
respectively. All p values were <0.01 (Fig. 1). This 
represents an 8%, 7%, and 17% increase for the 
mean systemic blood pressure and a 15%, 28%, and 
54% increase for the mean pulmonary blood pres- 
sure. The proportional increases in mean pulmonary 
arterial pressures are greater than the increases in 
the systemic arterial pressures (p < 0.01) (Table I). 
Although the blood pressures ultimately in- 
creased, they decreased immediately after the endo- 
thelin injection. The animals receiving 0 and 1.0 
/.~g/kg showed a decrease in systemic blood pressure 
between 16 and 24 mm Hg. Animals receiving 10 
p,g/kg showed a drop in blood pressure 26 to 34 mm 
Hg below the baseline level. The decrease in the 
systemic blood pressure occurred 2 (_+2) seconds 
after endothelin i jection. The pulmonary artery 
pressure decreased 3 to 7 mm Hg 4 (+2) seconds 
after the endothelin-1 injection and was not differ- 
ent in the three groups. After 10 (_+2) seconds the 
systemic blood pressure rose rapidly and reached a 
plateau. 
Arteries usually had a normal appearance, al- 
though many were contracted (Fig. 2). The capillar- 
ies in both the tissue and casts appeared normal, but 
the veins regularly were contracted with focal con- 
strictions (Figs. 3 and 4). The diameters of the veins 
studied ranged from 12 to 311 /~m. Focal venous 
contraction increased with the increasing dosage of 
endothelin up to 1 /~g/kg. For animals given 0, 0.1, 
1.0, and 10.0 txg/kg of endothelin, the average 
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Fig. 2. Scanning electron micrograph shows cast of pul- 
monary artery with elongated imprints of its endothelial 
cell nuclei. Pulmonary arteries lack ring constrictions and 
were less often contracted. This lung cast was from rat 
given 1 /xg/kg of endothelin-1. Bar represents 30/xm, 
Table I. Blood pressures in animals given endothelin 
Fig. 3. Scanning electron micrograph of cast of pulmo- 
nary vein shows moderately deep ring constrictions in
animal that received 0.1 /xg/kg of endothelin-1. Bar rep- 
resents 50/xm. 
0.1 tzg/kg 1.0 tlg/kg 10 tzg/kg 
Before After Before After Before After 
Systemic systolic 127 (10) 152 (8) 130 (11) 153 (9) 127 (9) 176 (13) 
Systemic diastolic 81 (3) 98 (7) 82 (7) 100 (13) 84 (4) 118 (19) 
Systemic mean 96(5) 104 (5) 99 (7) 106 (7) 98 (5) 115 (6) 
Pulmonary systolic 19 (2) 24 (2) 21 (2) 27 (2) 20 (2) 31 (3) 
Pulmonary diastolic 9 (2) '11 (3) 11 (1) 14 (2) 10 (1) 15 (2) 
Pulmonary mean 13 (2) 15 (2) 14 (2) 18 (1) 13 (2) 20 (2) 
Numbers in parentheses are the standard deviation. The differences between before and after endothelin injection are all sig ificant a p < 0.01. 
contraction was 6.7% (_+4.4), 15.4% (+9.1), 23.3% 
(+10.1), and 14.4% (_+9.0), respectively (p < 0,01) 
(Fig. 5). For animals given 0, 0.1, 1.0, and 10.0/xg/kg 
of endothelin the average capillary diameters were 
6.2 (_+1.5) kern, 7.1 (+1.4)/xm, 9.7 (___1.6) Ixm, and 
9.0 (_+1.2) Izm, respectively (p < 0.01). For animals 
given 0, 0.1, 1.0, and 10.0 Izg/kg of endothelin, the 
average capillary interspace was 5.9 (_+3.6) txm, 5.2 
(_+3.1) tzm, 4.9 (+2.9) /xm, and 5.3 /xm (-+3.4), 
respectively (p < 0.01) (Figs. 6 and 7). 
The dose of endothelin correlated with the 
change in systemic systolic (r = 0.82, p < 0.01), 
systemic diastolic (r = 0.59, p < 0.01), systemic 
mean (r = 0.82, p < 0.01), pulmonary systolic (r = 
0.82, p < 0.01), pulmonary diastolic (r = 0.67, p < 
0.01), and pulmonary mean (r = 0.80, p < 0.01) 
pressures. The change in pulmonary pressures cor- 
related with the structural changes. The mean pul- 
monary blood pressure change correlated with ve- 
nous contraction (r = 0.35, p < 0.01), capillary 
diameter (r = 0.64, p < 0.01), and capillary in- 
terspace distance (r = -0.34,p < 0.01). The venous 
contraction was related to the capillary diameter 
(r = 0.26,p < 0.01) and the capillary interspace (r = 
0.09, p < 0.01). 
The multivariate regression showed that the ani- 
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Fig. 5. Graph shows that mean venous contraction (_+ stan- 
dard deviation) at sphincters, expressed in percentage ofdiam- 
eter, was highest in animals receiving 1/~g/kg endothelin-1. 
Fig. 4. This cast pulmonary vein with its roundreliefs 
of endothelial cell nuclei has contraction of about 40% 
of its diameter atits constricted site. This lung cast was from 
rat that received 0.1 /zg/kg of endothelin-1. Bar represents 
20/am. 
mal's body weight and age had an effect on venous 
contraction i addition to the blood pressure change 
caused by endothelin. When each variable was en- 
tered first into the regression, the change in blood 
pressure (F = 26.3, p < 0.01) had a greater effect 
than weight (F = 0.2, p was not significant) and age 
(F = 7.8, p < 0.01), but when the other variables 
were in the equation, the change in blood pressure 
(F = l l .6 ,p  < 0.01) had a lesser effect than weight 
(F = 36.2, p < 0.01) and age (F = 41,9, p < 0.01). 
Not surprisingly, these variables were interactive so 
that the effect of the change in pulmonary blood 
pressure on venous contraction was greater in the 
older animals (F = 22.2, p < 0.01), although the 
interactive term of weight and change in blood 
pressure was not significant (F = 0.01). Older and 
heavier animals also had greater contraction (F = 
14.8, p < 0.01 for the interactive term age times 
weight with the dependent variable contraction). 
Discussion 
Endothelin-1 had proportionally a greater effect 
on the pulmonary blood pressure than on the sys- 
temic blood pressure and pulmonary veins appeared 
Fig. a. Cast shows capillaries of alveolus and spaces 
between them. This lung cast was from rat that received 10 
/zg/kg endothelin-1. Bar represents 10/zm. 
more constricted than pulmonary arteries in rats. 
Others have reported that pulmonary veins are 
more sensitive to endothelin-1 than arteries in 
sheep 21'43 and rabbits. 34 Small pulmonary veins 
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Fig. 7. Stippled bar shows mean capillary diameter (in microns) increased in rats given endothelin-1. Solid 
bars show that capillary interspaces (in microns) decreased. Error bars represent standard eviation. 
have termed venous sphincters. 29' 3o By casting and 
fracturing the casts we can measure the contractions 
of the individual veins at specific onstriction points. 
Endothelin caused more constriction of these struc- 
tures than any other stimulus that we have studied 
so far. 29' 44 Although it clearly appeared that the 
veins contracted more than arteries, the comparison 
may not be fair because we could precisely measure 
the focal constriction of veins that pinch with ring- 
like narrowness. Arteries, with their thicker muscu- 
laris, contract by a broad narrowing on the cast, 
which makes their contraction less obvious and 
impossible to measure xactly. 
We used corrosion casting to describe the effect of 
endothelin on the microvasculature. Scanning elec- 
tron microscopy of corrosion casts allows direct 
observation in three dimensions and measurement 
of large segments of the microvasculature. We can 
visualize where and how frequently the small blood 
vessels contract and we can see associated structural 
changes. We can rather precisely measure the depth 
of an individual contraction of small veins. The 
methacrylate r sin passes into all parts of the vas- 
cular tree. The pressure applied to the syringe to fill 
the vasculature with the resin depends on its state of 
polymerization and the amount of resistance n- 
countered before the resin reaches the desired 
vascular bed. The pressure cannot be measured at 
the capillary bed, but when the methacrylate is
injected through the caudal vena cava, the aortic 
(venting) pressure during the injection is nearly 
zero. 36 Damage to the delicate pulmonary capillary 
bed, if it should occur, can be detected by electron 
microscopy.31, 45 Although this technique gives use- 
ful information and is probably the only one that 
could answer the questions we asked, it has limita- 
tions. Like most other microscopic investigations it 
is static and requires familiarity with the normal and 
pathologic anatomy. Many landmarks of light mi- 
croscopy are not present and it does not give the 
intracellular detail of transmission electron micros- 
copy o f  tissue. We always use light microscopy of 
tissue in conjunction with the scanning electron 
microscopy of casts, but find new information more 
often studying the casts than the tissue. Appropriate 
controls are essential to determine the changes 
caused by any agent. 
To account for the greater sensitivity to endothe- 
lin, veins could have more endothelin receptors or 
the receptors on veins could have greater affinity for 
endothelin-1. 21 The receptors in the pulmonary 
vessels for  endothelin-1, 2, and 3 have different 
affinities for the different endothelins. 46' 47 Another 
explanation may be that endothelin can more easily 
reach venous than arterial smooth muscle because 
pulmonary veins lack the continuous internal elastic 
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lamina that pulmonary arteries have. 48 Endothelin 
may also act on adrenergic neural transmission in 
addition to its direct effect on smooth muscle cells, 49 
although our studies indicate that nerve endings are 
rare in the wall of rat pulmonary veins. 3~ 31 
The average capillary diameter may have in- 
creased because the capillaries were fuller as a 
result of venous contraction. The size of the 
capillary interspace may be decreased because of 
passive distension of the capillaries. The struc- 
tural differences hown here were greater when 
the dose of endothelin was considered as a class 
variable in the multivariate analysis, which means 
that the structural changes in the capillaries do 
not respond in a linear, dose-dependent manner 
in the doses we used. This may be because the 10 
/xg/kg dose of endothelin was not more potent 
than the 1.0 /xg/kg dose of endothelin, but more 
likely indicates that the expansion of capillaries is 
limited to about 9/xm and the intercapillary space 
will decrease only so far in response to an acute 
stimulus, which was reached with the 1 /xg/kg 
dose. 
We have associated contraction of pulmonary 
venous sphincters with pulmonary edema, z9-31 and 
other workers have found that endothelin-1 
causes pulmonary edema in rats and dogs. 2~ En- 
dothelin levels increase in the plasma of patients 
who receive cyclosporine after solid organ trans- 
plantation 5~ and in the pulmonary circulation of 
patients with mitral stenosis, l Other studies have 
shown that endothelin contracts liver sinusoids 52 
and is involved in the pathogenesis of ischemia 
and reperfusion liver injury after transplanta- 
tion. s3 Although the postoperative pulmonary 
edema may have many causes, this study adds to 
the evidence that sharp focal venous contractions 
are caused by endothelin and could be associated 
with pulmonary edema. Application of endothelin 
antagonists may be a potential adjunctive therapy 
after operation, especially in lung transplantation; 
but needs further study. Recent reports have 
shown that endothelin receptor antagonists can 
lower blood pressure and block cardiac hypertro- 
phy in experimental rat models of hypertension 
and circulatory overload. TM 55 Additional studies 
on injured and transplanted lung should further 
define these effects and are planned. 
We thank Mrs. Deborah Ellstrtim for excellent techni- 
cal assistance during blood pressure recording. 
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